-+ 0.00%
-+ 0.00%
-+ 0.00%

According to Zhitong Finance App, Shiyao Group (01093.HK) announced that the plugglitindagliptin metformin sustained-release tablets (this product) developed by the group have been approved by the China Drug Administration and can conduct clinical trials in China.

Zhitongcaijing·12/29/2025 10:33:07
Listen to the news
According to Zhitong Finance App, Shiyao Group (01093.HK) announced that the plugglitindagliptin metformin sustained-release tablets (this product) developed by the group have been approved by the China Drug Administration and can conduct clinical trials in China.